"Legend" about the time and variety of the second round of national joint mining

Special note: the content described in the following text is just a legend, just a guess Please do not take it as a "policy" Last week, many enterprises gathered in Shanghai to participate in the symposium, which is said to be organized by relevant departments The core idea is to exchange the internal practical views of relevant enterprises, including whether the income of employees of enterprises has been affected, etc since the state's joint mining and expansion According to the contents of the meeting, many foreign enterprises and generic pharmaceutical enterprises almost resonated and spoke at the same frequency They thought that the effect of the joint mining expansion was very good, the morale of the sales team was greatly improved, and the income of the employees of the enterprise was not affected On November 27, it was said that relevant departments also organized relevant meetings in Shanghai to discuss and exchange issues related to centralized drug procurement As for the tone of the meeting, some think it is to discuss how to expand the scope and land, some think it is the time and relevant content of the second round of national joint mining Not long ago, I received an online report It is said that the relevant provinces last week have received the notice of the second round of national centralized purchase documents The catalogue has about 37-40 varieties, and the preliminary plan is to start after the Spring Festival However, there have been different opinions on how to determine and start the varieties in the industry recently As for the determination of varieties, it mainly comes from the relevant requirements of last week's executive meeting of the State Council The main contents of the meeting include expanding the scope of centralized procurement and use of drug varieties, giving priority to the varieties with large price difference between the original research drug and generic drug, and the essential drugs through the consistency evaluation of the quality and efficacy of generic drugs, so as to promote the essence of drug price with quantity procurement Sex decreased We will build a national centralized procurement platform for drugs, and build a unified and open procurement market nationwide based on provinces (districts, cities) This is undoubtedly the way of thinking of the state's joint mining in the future At present, the national joint procurement mainly aims at 1 (original research) + 2 (over evaluation) varieties with high procurement amount However, with the setting of the relevant meeting of the State Council on centralized procurement, it is believed that the procurement direction will incline to the over evaluation varieties with basic drug status As for the start-up time, there are about three versions circulating in the industry One version starts in February 2020 If it is set according to the current bidding scope, it is not expected to be so fast The second version starts in June 2020, and the other version is expected to officially start in September 2020 I personally understand that if there is no clear change in the original procurement direction, February 2020 is a high probability event But as the executive meeting of the State Council sets the tone again on drug bidding and purchasing, it will be a question mark whether it can be carried out as scheduled in February.